raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:2137

Autoimmune hepatitis

Synonyms: AIH

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Adolescent, Adult, Childhood, Elderly
Status
active

A rare liver disease characterized by immune-mediated, acute or chronic liver inflammation, clinically presenting as cryptogenic hepatitis, with interface hepatitis on histological examination, elevated serum aminotransferase levels, and hypergammaglobulinemia / elevated immunoglobulin G, in the presence or absence of specific circulating autoantibodies. Patients may be asymptomatic, chronically ill, or present with acute liver failure. Concurrent autoimmune diseases are frequently observed.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAutoimmune hepatitisAIH
frHépatite auto-immuneHAI
deHepatitis, autoimmune= en
esHepatitis autoinmuneHAI
itEpatite autoimmuneEpatite autoimmune
nlAuto-immune hepatitis= en
ptHepatite auto-imune
plAutoimmunologiczne zapalenie wątrobyPrzewlekłe autoimmunologiczne zapalenie wątroby
csChronická autoimunitní hepatitidaAutoimunitní hepatitida
ukАутоімунний гепатит= en
zh自身免疫性肝炎= en
trOtoimmün hepatit= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10K75.4Especificvalidated
ICD-11DB96.0Especificvalidated
MONDO0016264Evalidated
UMLSC4721555Evalidated
GARD5871Evalidated
MedDRA10003827Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

Children (3):

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

17 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-5 / 10 000—EuropeClass onlyNot yet validatedORPHANET
Annual incidence1-9 / 100 0001.2 / 100 000WorldwideValue and classNot yet validatedORPHANET_24326217[PMID]
Point prevalence1-5 / 10 00023.5 / 100 000WorldwideValue and classNot yet validatedORPHANET_24326217[PMID]
Annual incidence1-9 / 1 000 0000.75 / 100 000EuropeValue and classValidated[EXPERT]
Annual incidence1-9 / 100 0001.9 / 100 000NorwayValue and classValidated9489916[PMID]
Point prevalence1-5 / 10 00016.9 / 100 000NorwayValue and classValidated9489916[PMID]
Annual incidence1-9 / 1 000 0000.85 / 100 000SwedenValue and classValidated18609163[PMID]
Point prevalence1-5 / 10 00024.5 / 100 000New ZealandValue and classValidated20880179[PMID]
Annual incidence1-9 / 1 000 0000.95 / 100 000SpainValue and classValidated15056409[PMID]_20163033[PMID]_ORPHANET
Point prevalence1-5 / 10 00011.6 / 100 000SpainValue and classValidated15056409[PMID]
Point prevalence1-5 / 10 00010.7 / 100 000SwedenValue and classValidated18609163[PMID]
Annual incidence1-9 / 1 000 0000.67 / 100 000IsraelValue and classValidated23815477[PMID]
Point prevalence1-5 / 10 00011 / 100 000IsraelValue and classValidated23815477[PMID]
Annual incidence1-9 / 100 0001.68 / 100 000DenmarkValue and classValidated24326217[PMID]
Point prevalence1-5 / 10 00023.9 / 100 000DenmarkValue and classValidated24326217[PMID]
Point prevalence1-9 / 100 0004 / 100 000SingaporeValue and classValidated11851837[PMID]
Point prevalence1-5 / 10 00042.9 / 100 000Specific populationValue and classValidated12358264[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

34 annotations · validated 2019-02-13
HPOTerm (as annotated by Orphanet)Diagnostic
Obligate (100%)
HP:0003237Increased circulating IgG level
HP:0010702Increased circulating immunoglobulin concentration
Very frequent (99-80%)
HP:0030909Anti-liver cytosolic antigen type 1 antibody positivity
HP:0003453Antineutrophil antibody positivity
HP:0003493Antinuclear antibody positivity
HP:0002910Elevated circulating hepatic transaminase concentration
HP:0030908Liver kidney microsome type 1 antibody positivity
HP:0031925Rosette
HP:0003262Smooth muscle antibody positivity
Frequent (79-30%)
HP:0002027Abdominal pain
HP:0032469Anti-asialoglycoprotein receptor antibody positivity
HP:0002829Arthralgia
HP:0012432Chronic fatigue
HP:0000716Depression
HP:0012522Spider hemangioma
Occasional (29-5%)
HP:0200119Acute hepatitis
HP:0000739Anxiety
HP:0001369Arthritis
HP:0001541Ascites
HP:0001394Cirrhosis
HP:0006555Diffuse hepatic steatosis
HP:0002239Gastrointestinal hemorrhage
HP:0000099Glomerulonephritis
HP:0003573Increased total bilirubin
HP:0002037Inflammation of the large intestine
HP:0000952Jaundice
HP:0030991Sclerosing cholangitis
HP:0001744Splenomegaly
HP:0100646Thyroiditis
HP:0100279Ulcerative colitis
HP:0001045Vitiligo
Very rare (<4-1%)
HP:0004787Fulminant hepatitis
HP:0001402Hepatocellular carcinoma
HP:0006562Viral hepatitis

Run the differential on the 9 obligate / very frequent terms

Annotation source: 30671977[PMID]_25920079[PMID]_28882739[PMID]_28432836[PMID]

7

Sources for this card